Updated January 30 at 9:30am
Biotechnology
25 results total, viewing 1 - 10
IlluminOss Medical has been issued two patents related to its internal bone fixing system, the company announced Tuesday. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
The co-founder and president of MedMates, Rhode Island’s first health care technology network group, and co-founder and director of an emerging health-tech company, Aspiera Medical, talks about starting a company in Rhode Island and what he expects MedMates to look like down the road. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported. more
1 | 2 | 3 Next »